The Human Liver Models Market: Global Analysis & Outlook (2017-2022) featuring Emulate, Ascendance Bio, HREL, CN Bio, Organovo, and Cyfuse Biomedical - ResearchAndMarkets.com
The "Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The global human liver models market is projected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6%.
The growth of this market is primarily driven by factors such as the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.
Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. In 2017, the animal models segment accounted for the largest share of the global market. The growth in the biosimilars market is expected to boost the preclinical market as the development of biosimilars and biopharmaceuticals requires an understanding of the mechanism of action, quantification of pharmacological effects, and interpretation of toxicological data.
As animal models are indispensable for learning the disease pathogenesis and progression in humans, the rising demand for preclinical services is expected to drive the demand for animal models.
However, the liver-on-a-chip segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to that of the in vivo environment.Companies Profiled
- Ascendance Bio
- CN Bio
- Cyfuse Biomedical
1 Market Overview for Human Liver Models
2 Industry Speaks - In Vitro Liver Models
3 Human Liver Model Market, By Drug Discovery Platform
4 Geographic Assessment
For more information about this report visit https://www.researchandmarkets.com/research/dcd27c/the_human_liver?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181024005430/en/